Consistently, the altered expression of CASP3, CASP4, GSDME, NLRC4, NLRP6, NOD1 and PLCG1 also corresponded with favorable or unfavorable OS in HCC patients according to the KM analysis (Figure 7B). This evidence concerns the gene CASP4 and hepatocellular carcinoma.